BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients-Reference-Cited by-同舟云学术

BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients

Published:2019-01-11 Issue:3 Volume:174 Page:775-783
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Friedlaender Alex,Vuilleumier Aurélie,Viassolo Valeria,Ayme Aurélie,De Talhouet Solène,Combes Jean-Damien,Peron Julien,Bodmer Alexandre,Giraud Sophie,Buisson Adrien,Bonadona Valerie,Gauchat-Bouchardy Isabelle,Tredan Olivier,Chappuis Pierre O.,Labidi-Galy S. Intidhar^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-018-05127-2.pdf

Reference35 articles.

1. Foulkes WD (2008) Inherited susceptibility to common cancers. N Engl J Med 359(20):2143–2153

2. Kuchenbaecker KB et al (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 MUTATION CARRIERS. JAMA 317(23):2402–2416

3. Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108(2):171–182

4. Nik-Zainal S et al (2016) Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534(7605):47–54

5. Roy R, Chun J, Powell SN (2011) BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer 12(1):68–78

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni Syndrome;JCO Precision Oncology;2024-06

2. The occurrence and risk factors of chemotherapy-induced neutropenia in patients with breast cancer not receiving primary G-CSF prophylaxis;ecancermedicalscience;2023-11-02

3. Extreme acute radiation‐induced toxicity in a patient with polymorphous low‐grade adenocarcinoma of the nasopharynx and rare variants in DNA repair genes;Head & Neck;2023-10-22

4. An overview of the research progress of BRCA gene mutations in breast cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-07

5. Hematologic toxicities of chemotherapy in breast and ovarian cancer patients carrying BRCA1/BRCA2 germline pathogenic variants. A single center experience and review of the literature;Familial Cancer;2023-04-29